Logo image
Effect of Advanced Age on Stereotactic Radiosurgery Outcomes for Brain Arteriovenous Malformations: A Multicenter Matched Cohort Study
Journal article   Peer reviewed

Effect of Advanced Age on Stereotactic Radiosurgery Outcomes for Brain Arteriovenous Malformations: A Multicenter Matched Cohort Study

Ching-Jen Chen, Dale Ding, Hideyuki Kano, David Mathieu, Douglas Kondziolka, Caleb Feliciano, Rafael Rodriguez-Mercado, Darrah E. Sheehan, Inga S. Grills, Gene Barnett, …
World Neurosurgery, Vol.119
2018

Abstract

Adult Age Factors Aged Aged, 80 and over Female Follow-Up Studies Humans Intracranial Arteriovenous Malformations Male Middle Aged Radiosurgery Retrospective Studies Treatment Outcome adult age aged all cause mortality Article artificial embolization brain arteriovenous malformation brain artery aneurysm brain hemorrhage cohort analysis digital subtraction angiography external beam radiotherapy female follow up gamma knife radiosurgery human Kaplan Meier method major clinical study male multicenter study nuclear magnetic resonance imaging radiation dose retrospective study scoring system stereotactic radiosurgery treatment outcome brain arteriovenous malformation clinical trial middle aged radiosurgery very elderly
Background: The effect of age on adult brain arteriovenous malformation (AVM) outcomes after stereotactic radiosurgery (SRS) remains unclear. The aim of this study is to compare AVM outcomes between elderly (age ≥60 years) and nonelderly adult patients. Methods: We retrospectively reviewed pooled data comprising patients who underwent SRS for AVMs between 1987 and 2014 at 8 centers participating in the International Gamma Knife Research Foundation. Adult (age ≥18 years) patients with ≥12 months follow-up were dichotomized into elderly and nonelderly cohorts, and matched in a 1:1 ratio. Favorable outcome was AVM obliteration without permanent symptomatic radiation-induced changes (RIC) or post-SRS hemorrhage. Results: The study cohort consisted of 1845 patients (188 elderly vs. 1657 nonelderly) who met the inclusion criteria, and subsequent matching resulted in 181 patients in each cohort. In the matched cohorts, rates of obliteration (54.7% vs. 64.6%; P = 0.054) favorable outcome (51.4% vs. 61.3%; P = 0.056) were no different between the elderly and nonelderly cohorts. The rates of post-SRS hemorrhage (9.9% vs. 5.5%; P = 0.115), RIC (26.5% vs. 30.9%; P = 0.353), symptomatic RIC (9.4% vs. 9.4%; P = 1.000), and permanent symptomatic RIC (3.3% vs. 2.2%; P = 0.750) were also not significantly different between the elderly and nonelderly cohorts. Elderly patients with AVM did have a significantly higher rate of all-cause mortality (27.7% vs. 5.5%; P < 0.001). Conclusions: Advanced age does not seem to significantly affect obliteration or complication rates after SRS for AVMs. Although the decision to recommend intervention for AVMs in the elderly population is multifactorial, SRS may be a viable modality when treatment is deemed appropriate. © 2018 Elsevier Inc.

Metrics

6 Record Views

Details

Logo image